Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use REBINYN safely and effectively. See full prescribing information for REBINYN.REBINYN® (Coagulation Factor IX (Recombinant), GlycoPEGylated)lyophilized powder for solution for intravenous injectionInitial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
REBINYN, Coagulation Factor IX (Recombinant), GlycoPEGylated, is a recombinant DNA-derived coagulation Factor IX concentrate indicated for use in adults and children with hemophilia B (congenital Factor IX deficiency) for: •On-demand treatment and control of bleeding episodes •Perioperative management of bleeding • Routine prophylaxis to reduce the frequency of bleeding episodes Limitations of Use: REBINYN is not indicated for immune tolerance induction in patients with hemophilia B.
- generic_name
- coagulation factor ix recombinant, glycopegylated
- product_names
- coagulation factor IX recombinant, GlycoPEGylated
- ndc
- 0169-7905, 0169-7905-01, 0169-7905-97, 0169-7955, 0169-7955-11, 0169-7955-90, 0169-7009, 0169-7009-98, 0169-7901, 0169-7901-01, 0169-7901-97, 0169-7911, 0169-7911-11, 0169-7911-90, 0169-7902, 0169-7902-01, 0169-7902-97, 0169-7922, 0169-7922-11, 0169-7922-90, 0169-7903, 0169-7903-01, 0169-7933, 0169-7933-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en